骨腔填充物市場:現狀分析與預測(2024-2032年)

Bone Void Fillers Market: Current Analysis and Forecast (2024-2032)

出版日期: 2024年07月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

骨腔填充劑是一種醫療設備，旨在解決因受傷、疾病或手術造成的缺陷，並為患者康復提供合適的介質。這些材料能夠透過為受影響區域提供支撐、骨骼癒合和功能支持來增強骨骼結構。生物活性材料取自陶瓷、磷酸鈣、矽酸鹽生物玻璃、聚合物和膠原蛋白等天然產物。骨折、骨質疏鬆症和關節炎等骨科疾病的盛行率不斷上升，大大增加了對骨腔填充劑的需求。隨著世界人口老化，需要手術介入的肌肉骨骼損傷和疾病正在增加。根據 NHS 估計，到 2022 年，75 歲以上的人中約有 69% 患有肌肉骨骼疾病，而 25 歲至 44 歲的人中這一比例為 23%。女性罹患骨質疏鬆症的可能性是男性的 5 倍，關節炎的可能性是男性的 1.4 倍。

在預測期（2024-2032 年），骨腔填充劑市場預計將以 6.8% 的複合年增長率大幅增長。這是由於對研發的持續投資，這對於開發更俱生物相容性、耐用性和有效促進骨癒合的創新骨腔填充劑至關重要。這包括探索新的生物材料，例如模仿天然骨骼特性的合成聚合物和生物陶瓷。 2021 年 9 月，專注於脊椎和骨科的全球醫療器械公司 Orthofix Medical Inc. 宣布推出 Opus Mg Set 骨傳導支架，這是一種用於骨科手術的合成鎂基骨空隙填充物。

依類型劃分，市場分為去礦骨、膠原蛋白基質、硫酸鈣基質和磷酸三鈣。 2023年，脫鈣骨將佔據壓倒性的市場。這主要是由於其獨特的生物學特性和多功能的骨科和脊椎外科應用。隨著對微創手術和生物相容性材料的需求不斷增加，脫礦骨仍然是不斷擴大的骨腔填充劑市場的基石。例如，2022 年10 月，Orthofix Medical Inc. 宣布全面上市Legacy 脫礦骨基質(DBM)，這是一種用於填充脊柱、骨盆和四肢骨缺損和創傷中的空隙和間隙的油灰，以及第一個植入物宣布。此外，外科醫生更喜歡脫礦骨，因為它具有骨傳導和骨誘導特性，可以提供結構支撐並刺激新骨生長。

依形式，市場分為凝膠顆粒、膏狀膩子等。預計在預測期內（2024-2032 年）凝膠顆粒將以顯著的複合年增長率成長。這些顆粒含有透明質酸和合成聚合物，天然類似骨頭的細胞外基質。這些支持細胞附著和生長，同時具有針對複雜骨缺損的水凝膠特性。隨著生物材料的進步，凝膠顆粒的新商機有望出現。申請人正在評估其適應骨科和重建手術中骨修復患者要求的能力。

根據最終用戶，市場分為醫院、專科診所等。到2023年，醫院將佔據壓倒性的市場佔有率。骨質疏鬆症、骨折綜合症和其他骨科疾病也變得越來越常見，需要有效的治療，例如填補骨缺損。例如，在美國(NHIS)，2019 年至2021 年，約5.4% 的18 至44 歲成年人報告患有關節炎，四分之一(26.0%) 的45 至64 歲成年人報告患有醫生診斷的關節炎。此外，醫院對於新技術和填充材料的臨床研究、評估其有效性並識別可能的不良反應至關重要。手術中先進儀器的使用和對病患治療結果的重視也是推動市場擴張的因素。

為了更了解骨腔填充劑的市場介紹，將市場分為北美（美國、加拿大等北美地區）、歐洲（德國、法國、英國、西班牙、義大利等歐洲地區）地區）、亞太地區（中國根據世界其他地區（日本、印度、亞太其他地區）和世界其他地區的全球影響力進行分析。亞太地區預計在預測期（2024-2032 年）將以顯著的複合年增長率成長。該地區正在經歷快速的經濟成長，隨著關節炎和其他骨科問題患者接受先進醫療程序的入院人數的增加，醫療保健領域的支出持續增加。亞太國家的人口老化正在引發骨質疏鬆、骨折和退化性關節炎等骨科問題。此外，3D 列印植入物和可生物降解的神經解剖填充物等技術正在成為服務領域的新興趨勢，因為它們與人體解剖結構精確匹配，術後感染的可能性較小。

市場上營運的主要公司包括 Stryker、Medical Device Business Services, Inc.（強生）、Medtronic、Zimmer Biomet、Smith+Nephew、Globus Medical、Orthofix Medical Inc.、Baxter Arthrex, Inc.、SeaSpine、 ETC。

Bone void fillers are medical devices designed to provide an appropriate medium for patient recovery by addressing defects as a result of injury, illness, or surgery. These materials offer capacity, which is enhanced by offering support for the skeletal structures, healing of the bones as well as the provision of functional support for the affected area. The bioactive materials can be derived from ceramics, calcium phosphate, silicate bioglasses, polymers, and natural products such as collagen. The rising prevalence of orthopedic disorders, such as fractures, osteoporosis, and arthritis, contributes significantly to the demand for bone void fillers. As the global population ages, there is an increase in musculoskeletal injuries and diseases that require surgical intervention. According to the NHS, in 2022, around 69% of people aged 75 and over were estimated to be living with a musculoskeletal condition, compared with 23% of people aged 25-44. females, compared with males, were 5 times as likely to be living with osteoporosis and 1.4 times as likely to be living with arthritis.

The Bone Void Fillers Market is expected to grow with a significant CAGR of 6.8% during the forecast period (2024-2032). This can be attributed to the continued investment in research and development, which is crucial to developing innovative bone void fillers that enhance biocompatibility, durability, and effectiveness in promoting bone healing. This includes exploring new biomaterials, such as synthetic polymers and bioceramics, that mimic natural bone properties. In September 2021, Orthofix Medical Inc., a global medical device company with a spine and orthopedics focus, announced the full market launch of the Opus Mg Set osteoconductive scaffold, a synthetic magnesium-based bone void filler for orthopedic procedures.

Based on the type, the market has been divided into demineralized bone, collagen matrix, matrix calcium sulfate, and tri-calcium phosphate. The demineralized bone held a dominant market share in 2023. This is mainly due to its unique biological properties and versatile orthopedic and spinal surgery applications. As demand for minimally invasive procedures and biocompatible materials grows, demineralized bone remains a cornerstone in the expanding bone void fillers market. For instance, in October 2022, Orthofix Medical Inc. announced the full market release and first implants of Legacy Demineralized Bone Matrix (DBM), a putty for filling voids or gaps in bony defects or traumatic injuries of the spine, pelvis, or extremities. Moreover, surgeons prefer demineralized bone due to its osteoconductive and osteoinductive properties, which provide structural support and stimulate new bone growth.

Based on the form, the market is segmented into gel granules, paste putty, and others. The gel granules are expected to grow with a significant CAGR in the forecast period (2024-2032). These granules include ongoing hyaluronic acid or synthetic polymers that naturally resemble the bone extracellular matrix. They support cell attachment and growth while at the same time are hydrogel in nature to assume complex bone defects. New opportunities for gel granules are anticipated to emerge as biomaterials advance; applicants value their ability to adapt to patient's requirements in regard to bone restoration during orthopedic and reconstructive operations.

Based on the end-user, the market is segmented into hospitals, specialty clinics, and others. Hospitals held a dominant share of the market in 2023. Osteoporosis, fracture syndromes, and other orthopedic diseases also become more frequent, requiring effective remedies for their treatment, for example, the filling of bone defects. For instance, from 2019 to 2021 in the United States (NHIS), around 5.4% of adults 18 to 44 years old reported arthritis, and Among adults aged 45 to 64 years, one-in-four (26.0%) reported doctor-diagnosed arthritis. Moreover, hospitals are essential players in the clinical research of new technologies and materials for fillers, assessments of their effectiveness, and identification of possible negative consequences. The use of sophisticated instruments in surgeries and their focus on patients' outcomes are other factors that will help expand the market.

For a better understanding of the market adoption of bone void fillers, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2032). The region is experiencing rapid economic growth, and the healthcare sector expenditures continue to rise with improved admission to sophisticated medical procedures for patients with diseases such as arthritis and other orthopedic problems. An older population base in Asia-Pacific countries results in an emerging concern of orthopedics, which comprises osteoporosis, bone fractures, and degenerative arthritis. Furthermore, techniques like 3D printed implants and biodegradable neuroanatomy fillings are emerging trends for the services as they provide the exact fit of the human anatomy and give less chance of post-surgery infection.

Some of the major players operating in the market include Stryker, Medical Device Business Services, Inc. (Johnson & Johnson), Medtronic, Zimmer Biomet, Smith+Nephew, Globus Medical, Orthofix Medical Inc., Baxter Arthrex, Inc., SeaSpine.

1.MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Bone Void Fillers Market
2.2. Research Methodology of the Bone Void Fillers Market
2.3. Respondent Profile

3.EXECUTIVE SUMMARY

3.1. Industry Synopsis
3.2. Segmental Outlook
- 3.2.1. Market Growth Intensity
3.3. Regional Outlook

4.MARKET DYNAMICS

4.1. Drivers
4.2. Opportunity
4.3. Restraints
4.4. Trends
4.5. PESTEL Analysis
4.6. Demand Side Analysis
4.7. Supply Side Analysis
- 4.7.1. Merger & Acquisition
- 4.7.2. Investment Scenario
- 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

5.1. Regional Pricing Analysis
5.2. Price Influencing Factors

6.GLOBAL BONE VOID FILLERS MARKET REVENUE (USD BN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

7.1. Demineralized Bone
7.2. Collagen Matrix
7.3. Matrix Calcium Sulfate
7.4. Tri-Calcium Phosphate
7.5. Others

8.MARKET INSIGHTS BY FORM

8.1. Gel Granules
8.2. Paste Putty
8.3. Others

9.MARKET INSIGHTS BY END-USER

9.1. Hospitals
9.2. Specialty Clinics
9.3. Others

10.MARKET INSIGHTS BY REGION

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. France
- 10.2.3. UK
- 10.2.4. Spain
- 10.2.5. Italy
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Rest of APAC
10.4. Rest of the World

11.VALUE CHAIN ANALYSIS

11.1. Marginal Analysis
11.2. List of Market Participants

12.COMPETITIVE LANDSCAPE

12.1. Competition Dashboard
12.2. Competitor Market Positioning Analysis
12.3. Porter Five Forces Analysis

13.COMPANY PROFILES

13.1. Stryker
- 13.1.1. Company Overview
- 13.1.2. Key Financials
- 13.1.3. SWOT Analysis
- 13.1.4. Product Portfolio
- 13.1.5. Recent Developments
13.2. Medical Device Business Services, Inc. (Johnson & Johnson)
13.3. Medtronic
13.4. Zimmer Biomet
13.5. Smith+Nephew
13.6. Globus Medical
13.7. Orthofix Medical Inc.
13.8. Baxter
13.9. Arthrex, Inc.
13.10. SeaSpine